Recap: Harvard Bioscience Q1 Earnings

 

Harvard Bioscience HBIO reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Harvard Bioscience missed estimated earnings by 20.0%, reporting an EPS of $0.04 versus an estimate of $0.05.

Revenue was up $1.79 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 7.94% increase in the share price the next day.

Here's a look at Harvard Bioscience's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 0.10 0.06 0.06 0.03
EPS Actual 0.08 0.06 0.06 0.05
Revenue Estimate 32.96M 27.91M 27.67M 25.73M
Revenue Actual 33.05M 29.66M 29.20M 26.99M

To track all earnings releases for Harvard Bioscience visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!